Dangerous Lipitor Side Effects

lipitor lawsuit

Many healthcare consumers are being hurt by the popular and commonly used drug. Fight back with a Lipitor lawsuit.

Pfizer is currently being sued by hundreds of consumers who took the prescription drug Lipitor, a cholesterol lowering medication.

Lipitor belongs to a class of drugs known as statins. Lipitor is a particularly potent statin, and consequently is more prone to causing Lipitor side effects.

While Lipitor is indeed effective at lowering cholesterol levels, consumers are reporting serious side effects and illnesses as a result of taking this drug.


Some of the more severe complications of taking Lipitor can include:

  • Rhabdomyolysis
  • Type II diabetes
  • Muscle problems
  • Kidney damage
  • Liver problems

The number of Lipitor lawsuits is skyrocketing because Pfizer failed to appropriately warn consumers of the risks of taking Lipitor.

If Pfizer had been responsible in warning the public about the risks involved with taking this drug, consumers and healthcare providers could have taken the necessary steps to help prevent some of these complications from arising.

Currently, litigation is focusing on post-menopausal women with a BMI (body mass index) of 32 or lower who took Lipitor and subsequently were diagnosed with type II diabetes. However, we still recommend you contact us for free claims advice even if you don’t fall into this category, as you may be eligible for a Lipitor lawsuit.

For example, claims that Lipitor can lead to rhabdomyolysis, a condition involving the breakdown of muscle tissue are surfacing left and right.

If you have been adversely affected by Lipitor you may be eligible for compensation. Click here for more information on the Lipitor rhabdomyolysis connection.

Lipitor Causes Type II Diabetes

Thousands of Lipitor consumers are receiving terrible news: they have now developed type II diabetes as a direct result of taking Lipitor.

This news is shocking patients across the country, as Pfizer has not been forthcoming to the public that this medication significantly increases the risk of contracting type II diabetes.

Post-menopausal women are particularly at risk for developing diabetes while taking Lipitor, although other populations such as men and pre-menopausal women are also being affected.

Several scientific studies over the past decade have confirmed the fact: Lipitor significantly increases the risk of developing type II diabetes, especially in post-menopausal women. Read more about these studies by clicking here.

These are women who would not otherwise be at risk for diabetes, women who now have to live with this chronic and life-changing disease.

How could Lipitor Cause Type II Diabetes?

lipitor type 2 diabetesAlthough scientists have established a clear causal relationship between Lipitor and type II diabetes (meaning they have found that Lipitor indeed causes type II diabetes to develop), exactly how this happens is still unclear.

Studies have shown that taking Lipitor or other statins decreases the body’s ability to control blood sugar levels. People who take Lipitor often have abnormally high blood sugar.

Scientists suspect that the drug may be interfering with the pancreas’ ability to produce insulin, and/or decrease the body’s sensitivity to insulin.

Insulin is a hormone that lowers blood sugar levels when released into the bloodstream. The cells of the body (muscle cells for instance) need sugar for energy.

The particular kind of sugar the body uses to fuel its cells is called glucose.

Insulin signals cells to take in more glucose (aka sugar), thus removing the sugar from bloodstream as it moves into the various different kinds of cells in the body.

Type II diabetes develops when the body stops producing enough insulin, or when the cells stop responding properly to the insulin.

When there isn’t enough insulin, or the insulin isn’t working properly a person’s blood sugar level will rise, because the sugar is no longer being moved into the cells, and builds up in the bloodstream instead.

You may have heard the term “insulin resistance” before. Insulin resistance means that the body’s cells have stopped responding properly to the insulin, which causes the blood sugar levels to rise.

The exact physiological pathways that cause type II diabetes are still unknown, but we know it has to do with decreased insulin production, and insulin no longer working as it should, which is exactly what long-term use of Lipitor does to the body.

If you are taking Lipitor, it is important that you monitor your blood sugar levels, and be aware of the early signs of type II diabetes to protect yourself from this dangerous and chronic illness.

The Lipitor Lawsuits

Lipitor settlement lipitor lawsuitConsumers affected by this drug are now in the process of suing Pfizer for their gross negligence in failing to warn the public about the extreme and severe side effects Lipitor causes.

The Lipitor lawsuit claims allege that Pfizer either knew, or should have known about the more dangerous side effects of Lipitor, because the pharmaceutical companies are required to test their drugs thoroughly before releasing them onto the market for sale.

Another problem is that they failed to warn the consumers properly. For example, in 2012 the FDA mandated Pfizer to add a warning about type II diabetes on the Lipitor label. Instead of making a clear warning, Pfizer was elusive and did not come out and say directly that Lipitor could cause diabetes.

One of the Lipitor lawsuit claimants commented, “The warning might as well have been Greek to me.”

The litigation currently focuses on post-menopausal women with a BMI of 32 or lower who have contracted type II diabetes, as there have been numerous medical institutions publishing conclusive scientific evidence of how Lipitor increases the risk of type II diabetes for these women.

However, it would appear that Lipitor can cause diabetes in other populations as well, such as men or pre-menopausal women.

If you have been hurt by Lipitor it is important to contact us and see if you are eligible for a Lipitor lawsuit claim, because he medical bills resulting from the various Lipitor side effects can be very costly.

The Lipitor Settlement

The Lipitor settlement is imminent. Lipitor side effects have hurt many of their users and the resulting medical bills can be very costly.

In addition to medical bills, Lipitor users may experience a decrease in quality of life, as well as lost wages due to illnesses or injuries caused by Lipitor.

It is also possible that Pfizer may be ordered to pay punitive damages as part of the compensation for Lipitor. Punitive damages are additional amounts of compensation the defendant has to pay which are meant to discourage them from repeating such negligence in the future.

We at Consumer Claims Center of America are helping those who have been hurt by Lipitor fight back. Don’t hesitate to contact us today for a free case evaluation. We will help you get the Lipitor settlement you deserve.

Fill out our Lipitor Lawsuit Form on the top right-hand corner of this page, or call our toll-free number below to start your Lipitor lawsuit today!


Lipitor Claims Continue to Increase

Lipitor Lawsuit Now has Nearly 1,000 Claimants

According to a report released July 15th, 2014 the Lipitor lawsuit now has 959 claims.

Claimants in the Lipitor lawsuit are people who have been diagnosed with type II diabetes as a side effect of Lipitor.

At Consumer Claims Center of America, we speak with these clients every day, and are happy that the lawsuit is now moving forward so they can begin to recover their losses and move on.

The number of claimants in the Lipitor lawsuit is growing rapidly.

The number of claimants in the Lipitor lawsuit is growing rapidly.

The Lipitor Multidistrict Litigation, or Lipitor MDL is becoming larger, having more than doubled in size since earlier this year.

After all, the number of claimants participating in the Lipitor MDL was originally reported to be 464 people in May of 2014. This number grew to 703 claimants in just one month, as of April 2014.

The new report counts 959 claims as of mid-July, and the number is expected to keep rising.

Pretrial procedures are already underway in the Lipitor lawsuit. The Lipitor MDL is formed and operational.

Click here to learn all about the Lipitor MDL.

The Lipitor Lawsuit

The Lipitor lawsuit has been building ever since the FDA adjusted Lipitor warning labels back in 2012.

The FDA mandated that the manufacturer add a warning that the pill may cause type II diabetes. However, claimants argue that the new warning label was too late, and also confusing and indirect.

Claimants in the Lipitor lawsuit share common complaints:

1. They have been diagnosed with type II diabetes and allege that they developed the diabetes as a side effect of Lipitor. Studies have shown that taking Lipitor, a cholesterol lowering medication, significantly increases one’s risk of developing type II diabetes. This risk is especially high in postmenopausal women.

2. They allege that Pfizer, the manufacturer of Lipitor, did not properly warn them of their increased risk of diabetes.

It is likely that Pfizer knew about the risk of developing diabetes with Lipitor well before they ever adjusted their warning labels. Also, even though they did add some sort of a warning, it did not come out and say “diabetes.” Instead it was worded in such a way that only medical professionals would understand it.

Plaintiffs allege that had Pfizer been more open about the risks of Lipitor diabetes they would have been able to take certain precautionary measures to prevent developing the full blown disease, such as regularly monitoring their blood sugar levels.

Nine hundred fifty nine is a large number. It’s not just a number, it’s people –  people who have been seriously hurt by Pfizer’s best selling drug Lipitor. The lawsuit is not frivolous; its a public outcry that says “this is not ok.”

The time to file your Lipitor lawsuit claim is now. The Lipitor lawsuit is currently in court.

The time to file your Lipitor lawsuit claim is now.

If you have been hurt by Lipitor, the time to fight back is now. We offer a free claims evaluation, work with the best lawyers, and can help you every step of the way with your Lipitor claim – it’s what we do.

Fill out the online claims form on the right hand corner of this page, or simply call the number below to get started right away.


New Science on Lipitor Diabetes Connection

New Study on Lipitor Diabetes

Lipitor Causes DiabetesThis new study was just published on June 26, 2014 in Diabetes Care. It investigates the connection between adherence with statin therapy and development of new diabetes.

By “adherence with statin therapy” we mean how often a person takes their statin drug- if they take it regularly as prescribed by the doctor, or more or less often.

Lipitor is a statin. Statins are a class of cholesterol lowering drugs used for the prevention of heart disease. Statins are also known to increase the user’s risk of developing type II diabetes.

First, the authors of the study did confirm that statin therapy (taking Lipitor) does in fact increase risk of diabetes.

Second, they found that adherence to medication schedules has an effect on the risk of diabetes.

Lipitor patients with low adherence (ie Lipitor users who do not take it as often as the doctor says they should) had a lesser risk for developing diabetes.

Taking statins for any period of time increases your risk of developing type II diabetes. However, the authors of this study found the risk is less in those who did not take it as much as they were prescribed to, and higher in those who took it as prescribed.

This is not in any way saying you should take less of your medication if you currently are on Lipitor or another statin. All medication changes should be discussed with your healthcare provider first.

“Essentially, the statin-diabetes effect is real. The key message for clinicians is to reiterate strongly that patients can offset diabetes risk once on a statin by taking lifestyle changes seriously.” – Dr. Sattar, MD, PhD, Professor of metabolic medicine at University of Glasgow.

However, plaintiffs in the Lipitor lawsuit allege that Pfizer never gave them a chance.

Pfizer Failed Consumers

Lipitor was approved by the FDA for sale in late 1996. Before a pharmaceutical company can publicly sell a drug, they are required to go through rigorous testing to make sure the drug is safe and effective. It is the pharmaceutical companies legal responsibility to make sure their drugs are safe before selling them.

Plaintiffs in the Lipitor lawsuit do not see how Pfizer could have missed the Lipitor diabetes link. In fact, many say they couldn’t have, and just chose not to disclose warnings about Lipitor type II diabetes. Other serious side effects, such as Lipitor rhabdomyolysis are also becoming aproblem for Lipitor consumers.

In 2012 after more and more scientific evidence piled up showing the Lipitor diabetes connection, the FDA finally began requiring Pfizer to add a warning on Lipitor’s labeling.

The warning was supposed to warn people about the risk of developing type II diabetes while taking Lipitor and other statins. Instead, many Lipitor users found the warning confusing, and essentially useless.

You can decide for yourself, here is what the warning says:

“Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor.”

Do you feel as though that is a clear public warning about the risks of developing Lipitor diabetes?

One must ask: Is Pfizer looking out for our best interests by printing out that label? Or are they being intentionally deceitful, knowing that the vast majority of people reading it won’t understand that label?

Pfizer must be held responsible for their actions, which have put millions of people at risk.

A report came out last month declaring that 959 people have now joined the Lipitor lawsuit (commonly mistaken as a Lipitor class action lawsuit).

If you have been affected by Lipitor diabetes, the time to act is now. We can help you recuperate your medical bills, lost wages, and possibly additional damages like pain and suffering on a case by case basis.

Fill out the online form on this page, or call the number below to get started. We will evaluate your claim at no cost to you, and our Lipitor lawyers will only collect a fee if you collect your settlement.


Lipitor is more Dangerous than other Statins – Lipitor Diabetes

The science is in: Taking Lipitor increases your risks for developing type 2 diabetes.

Lipitor Diabetes ClaimsThe Lipitor diabetes studies mostly focus on postmenopausal women, but some evidence is showing that other populations, such as younger women and men, may be at risk for Lipitor diabetes as well.

Now, the numbers vary from study to study, and there isn’t a scientific consensus as to how much Lipitor increases one’s chances of developing type 2 diabetes.

After all, science isn’t perfect; it’s still subject to human interpretation and error. That being said, science is still the best tool we have at finding truth as we know it in this day and age.

Thus, some studies report as low as a 6% increase in the risk of developing diabetes while taking Lipitor, while others are as high as a 52% increase in diabetes risk when taking Lipitor.

Canadian researchers found that people taking Lipitor were 22% more likely to develop type 2 diabetes. This study also tested the diabetes risk associated with other statins as well.

Statins are a class of drugs that are used to lower cholesterol levels. Lipitor is an exceptionally potent statin.

The researchers found that compared to other statins,  Lipitor users have a higher risk of developing diabetes than those who are on different statin medications.Lipitor Diabetes Researcher

The researchers tested other statins such as Crestor, Zocor, and Pravachol. While they found they Lipitor
caused a 22% increase in diabetes risk, Crestor’s was a little lower at 18%.

Zocor was found to raise the risk of developing type 2 diabetes by only 10%, but what is really surprising, is the results they had with less potent statins such as Provachol, Mevacor, and Lescol.

Provachol, another statin, appeared to actually have a favorable effect on the diabetes risk, meaning it lowered users risks for developing type 2 diabetes.

Lescol too, was shown to lower the risk of developing diabetes by 5%. Mevacor caused a 1% decrease in diabetes risk.

The authors of this study used data from 500,000 patients in the Ontario area.

After doing the math, the authors of this study concluded that for every 162 to 407 patients taking Lipitor or other statins, one new person will develop diabetes.

This may not seem like a high number, but keep in mind that Lipitor is the most widely prescribed drug in the world.

Millions of people take Lipitor every day, and that number is expected to rise dramatically due to the new FDA approval. Earlier this year, Lipitor was FDA approved to be used as a preventative medication. It no longer just treats high cholesterol; it can also be prescribed to prevent it.

The Lipitor Lawsuits

If you have been affected by Lipitor type II diabetes, now is the time to fight back. You can have your medical bills, loss of wages, and more compensated for through the Lipitor lawsuit.

Contact Consumer Claims Center of America today to get started with a free claim evaluation. There is no obligation, and no cost to you unless you collect your Lipitor settlement.

We are dedicated claims advocate professionals, and we are here to help.



The Lipitor Plaintiffs’ Steering Committee

Lipitor Plaintiffs' Steering CommitteeThe Lipitor Plaintiffs’ Steering Committee, or Lipitor PSC is a group of lawyers who have been chosen to represent the plaintiffs in the Zoloft lawsuit.

If you are making a claim in the Lipitor lawsuit than the Lipitor PSC is defending you, the plaintiff.

Various leadership roles in the Lipitor lawsuit have now been assigned by the presiding Lipitor lawsuit Judge Richard Gergel.

Judge Gergel released an order on April 8th, 2014 appointing the members of the Lipitor Plaintiffs’ Steering Committee, or Lipitor PSC, as well as filled other leadership positions in the Lipitor lawsuit.

The Lipitor lawsuit is a multidistrict litigation, or Lipitor MDL. An MDL is a way of organizing big lawsuits such as the Lipitor lawsuit, saving everyone involved time and money.

When plaintiffs from all over the nation file similar complaints against a defendant such as Pfizer, the courts system will often decide to consolidate the many claims into one federal courtroom, to be heard by a US District judge. A multidistrict litigation is the consolidation of many similar claims into a single federal court, to handle pretrial proceedings.

An MDL handles pretrial proceedings; cases such as the Lipitor lawsuit are usually resolved in the pretrial stages.

The Honorable Richard M. Gergel.

The Honorable Richard M. Gergel.

This can either lead to the dismissal of the case, or a settlement offer from the defendant (Pfizer). If no settlement is agreed upon, then the case is then transferred back to the original court to be litigated.

In other words, if the Lipitor lawsuit is not either dismissed or settled in the MDL (federal) court, it will be transferred back to the original district the Lipitor claim was filed in, to go to trial.

Click here to learn all about the Lipitor MDL.

The US District Judge selected to lead the Lipitor MDL was Richard M. Gergel. It is the judge’s decision who gets appointed to the leadership roles and PSC in a case.

Leaders in the Lipitor Lawsuit

As of April 8th, 2014 the Honorable Judge Gergel appointed the following bar certified lawyers to the Zoloft Plaintiffs’ Steering Committee, or Zoloft PSC:

  • Margaret Branch
    (Branch Law Firm)
  • Chris Coffin
    (Pendley, Baudin & Coffin, LLP)
  • Ernie Cory
    (Cory, Watson, Crowder & DeGaris)

    Chris Coffin, member of the Lipitor PSC.

    Chris Coffin, member of the Lipitor PSC.

  • Martin Crump
    (Davis & Crump, PC)
  • W. Lewis Garrison, Jr.
    (Heninger, Garrison Davis, LLC)
  • Lisa Gorshe
    (Johnson Becker, PLLC)
  • Mike Heaviside
    (Heaviside Reed Zaic)
  • Catherine Heacox
    (The Lanier Law Firm PLLC)
  • Rob Jenner
    (Janet, Jenner & Suggs, LLC)
  • Casey Lott
    (Langston & Lott, PA)
  • Dianne Nast
    (Nast Law, LLC)
  • Frank Petosa
    (Morgan & Morgan, PA)
  • Lori Siler Restaino
    (Restaino Siler, LLC)
  • Joseph F. Rice
    (Motley Rice, LLC)
  • Nelson J. Roach 
    (Nix, Patterson & Roach, LLP)
  • Frank Woodson
    (Beasley, Allen, Crow, Methvin, Portis & Miles, PC)

Furthermore, Judge Gergel has appointed the following four lawyers to the Plaintiffs’ Executive Committee:

  • H. Blair Hahn
    (Richardson Patrick Westbrook and Brickman)
  • Jayne Conroy
    (Hanly & Conroy Bierstein Sheridan Fisher & Hayes, LLP)
  • Ramon R. Lopez
    (Lopez McHugh LLP)
  • David F. Miceli
    (Simmons Browder Gianaris Angelides and Barnerd)

Mark Charles Tanenbaum of Mark C Tanenbaum Law Office was appointed as Plaintiffs’ Liaison Counsel, and H. Blair Hahn of Richardson Patrick Westbrook and Brickman has been appointed as Plaintiffs’ Lead Counsel.

This is the group that will lead plaintiffs in the Lipitor lawsuit to success.

Click here to learn more about the leadership roles in the Lipitor Plaintiffs’ Steering Committee.

What We Do

Lipitor PSCAt Consumer Claims Center of America, we speed up the processing on your claim and make sure it gets to a qualified attorney working on the Lipitor lawsuit.

We work either directly, or indirectly with members of the Lipitor Plaintiffs’ Steering Committee, ensuring your claim gets the attention it deserves from the major lawyers on the case.

We will also keep you up to date on the latest news on your Lipitor claim.

We also provide a no obligation, free consultation. 

We are confident we can help you get the Lipitor settlement you’re entitled to. The Lipitor MDL is in session, and the Lipitor PSC is working hard for you. Contact us today to get your Lipitor lawsuit started.

Fill out the Lipitor lawsuit form on the upper right-hand corner of this page, or simply call the number below to start your claim evaluation immediately.


History of the Lipitor Lawsuit

History of Lipitor

Lipitor is Lipitor Lawyera cholesterol lowering medication, belonging to a class of drugs known as statins. Statins have been used since the 1980′s to lower cholesterol.

Statins work by blocking a specific enzyme in the liver, which stops the body from producing more cholesterol. Statins usually will lower cholesterol levels after a two week course of medication, but are typically taken for longer periods of time, even years.

Lipitor is also called atorvastatin, which is the generic name of the drug. Lipitor was originally developed Warner-Lambert, a pharmaceutical company.

Warner-Lambert entered into a selling agreement with Pfizer, Inc., who would market and sell the drug. Pfizer later acquired Warner-Lambert in 2000.

Lipitor was given FDA approval for public use in late 1996, and first sold in 1997. It quickly became the most popular drug of all time, outselling all other pharmaceutical medicines of any kind. In the first 14.5 years after it’s release, Lipitor grossed over $125 billion in sales.

Lipitor raked in 20 to 25% of Pfizer’s overall sales for years.

Part of the success of Lipitor was because it is a particularly potent statin, and is very efficient in lowering LDL cholesterol levels. It is sometimes nicknamed the “turbostatin.”

In addition, there are claims that Lipitor was aggressively marketed, downplaying the risks and dangerous Lipitor side effects, which may account for some of its success as well. For more on the Lipitor side effects, click here.

Problems are seen with Lipitor Side Effects

There have been many prior studies on statin use and the risk of type II diabetes, but it was until 2004 that a study specifically examining Lipitor and type II diabetes was published.

Lipitor Lawsuit Diabetes ClaimsThis study was published in Circulation, and it examined the relationship between Lipitor and blood sugar. It found that people who take long term courses of Lipitor can have worsened ability to control blood sugar levels. The authors of this study stated that Lipitor decreased “glycemic control.”

With uncontrolled blood sugar levels, people taking Lipitor can eventually develop type II diabetes.

Another study published by the Lancet in 2010 confirmed the association between Lipitor and other statins with type II diabetes. These researchers found that taking Lipitor leads to a significantly increased the users chances of developing type II diabetes.

Another study published by the Journal of the American College of Cardiology published in 2011 confirmed: Lipitor increases the users’ risk of contracting type II diabetes significantly.

These and other medical studies caught the attention of the U.S. Food and Drug Administration (FDA).

FDA makes Changes in Lipitor Safety Labels

Lipitor was approved for sale in 1996, but it wasn’t until 2012 when the FDA ordered changes to be made to the safety label of Lipitor regarding the Lipitor diabetes risk.

On February 28th, 2012 the FDA issued a mandate that the drug companies must add another safety label to Lipitor and atorvastatin, warning that this medicine may significantly increase one’s likelihood of developing type II diabetes.

Unlike in other countries, Pfizer chose not to disclose the diabetes risk on the Lipitor bottles directly. Instead Pfizer placed a warning that the drug can potentially cause increased blood sugar levels.

However, claimants in the Lipitor lawsuit argue that this warning was not strong enough, and unclear. The Lipitor type II diabetes warning Pfizer added in response to the FDA mandate was worded as follows:

“Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor.”

The Lipitor Lawsuit

As Lipitor users across the U.S. began to develop type II diabetes from taking Lipitor, a public outcry began. Lipitor was released 16 years before Pfizer began to warn about Lipitor type II diabetes, a warning that came all too late for thousands of Americans.

If Pfizer had been more forthcoming about the risks of type II diabetes to both patients and the healthcare providers prescribing this medication, preventative action could have been taken.

For example, healthcare providers could have started monitoring their patient’s blood glucose level to see if a problem was developing. Lipitor users themselves could have made life style changes had they known of their increased risk of contracting diabetes.

The first Lipitor lawsuit was filed in the District of South Carolina by Evalina Smalls. Evalinlipitor lawsuite began taking Lipitor in 1999 to prevent heart disease.

Despite her healthy lifestyle and otherwise low risk for diabetes, Evalina developed type II diabetes as a result of taking Lipitor. She alleges that she is now at risk of the complications associated with type II diabetes, including blindness, kidney disease, nerve damage, and yes, heart disease.

Evaline Smalls was not the only one affected, and the Lipitor lawsuits slowly started to increase. The Lipitor MDL , or Lipitor multidistrict litigation was created this year, as the number climbed from just a few Lipitor type II diabetes claims, to over 700. The Lipitor MDL will effectively organize the smiliar Lipitor type II diabetes claims and expedite pretrial procedures, including early settlements.

The Lipitor lawsuit is expected to go to trial in July of 2015.

Hurt by Lipitor?

If you have been affected by Lipitor type II diabetes, you may be eligible for compensation with a Lipitor lawsuit. The medical bills, risks, and pain and suffering associated with Lipitor type II diabetes are not to be underestimated.

If you have been hurt by Lipitor, it is vital that you contact our team for legal representation. Our Lipitor lawyers are experienced, caring, and well-qualified to handle your case.

Call today for a free case evaluation to see if you may have a viable claim for a Lipitor lawsuit.


The Lipitor Multidistrict Litigation

The Lipitor Multidistrict Litigation

The Honorable Richard M. Gergel.

The Honorable Richard M. Gergel.

The Lipitor type II diabetes claims have been consolidated into a multidistrict litigation (MDL), to be heard in the District of South Carolina by the Honorable Judge Richard M. Gergel.

This is good news to the plaintiffs in the Lipitor lawsuit, who have been petitioning for a multidistrict litigation since early 2013.

Let’s first gain an understanding of what an MDL is.

What is Multidistrict Litigation?

A multidistrict litigation, abbreviated as an MDL, is a a way of organizing legal claims that are similar in nature. They may share at least one common complaint, common plaintiffs, and/or a common defendant.

As is the case with Lipitor, sometimes there are hundreds or even thousands of lawsuit claims that are very similar in nature. These claims may be spread throughout the United States, in multiple states and court districts, which can make things complicated.

A multidistrict litigation is a way of grouping similar claims, and proceeding with the pre-trial steps to litigation in one courtroom, instead of several across the country.

Both the plaintiffs, and the defendant have a right to petition for a multidistrict litigation.

Who Decides if an MDL should be Created?

Lipitor multidistrict litigationThe US Judicial Panel on Multidistrict Litigation is a group of seven federal judges, and it is up to them to determine if an MDL is necessary. Their role is to make decisions on two primary issues:

1. Are the claims that are being brought forth alike enough to create an MDL?

For example: Are the claimants suing for the same reasons? Is the complaint being made against the same defendant? (In the case of Lipitor, the defendant is Pfizer.)

2. What judge, judges, or district should hear the case?

Once the Judicial Panel on Multidistrict Litigation decides to move forward and create an MDL, they will then choose an appropriate district and judge to hear the case. This is often based off of factors like where the plaintiffs or defendant are located.

In the case of the Lipitor lawsuit, many of the original complaints were filed in the District of South Carolina, which is where the new Lipitor MDL is located.

How an MDL Works

Consolidating claims into an MDL saves everybody time, money and effort. Pfizer no longer has to defend itself in multiple districts across the nation, and the plaintiffs now have the added benefit of having one judge and one court being experts in their case.

It is important to understand that an MDL is only for pre-trial proceedings and motions.

The claims are still considered individually in their original district once (and if) they actually go to court, but grouping them together for the pre-trial proceedings is simply more efficient for the court system, and often the plaintiffs and defendants involved as well.

Here, in the pre-trial stages,  the claims might be dismissed if the judge does not feel they are valid and fit for litigation. Or it is possible to reach a settlement at this point in the process. Large corporations often would rather settle than continue to trial.

It is the plaintiff’s right to either accept, or reject any settlement (compensation) offered at this point in the process. If they are unsatisfied with the settlement offered, they can then take the claim to court in their original district.

Thus, if the pre-trial process is complete, and the case is going to move on to trial, the claim will be transferred back to its original court district. At this point the defendant is no longer negotiating the settlement; any compensation offered at this stage will be determined by the judge and jury.

The Lipitor MDL

The Lipitor petition for an MDL was originally denied by the US Judicial Panel on Multidistrict Litigation, back in 2013.

At that time there were only a few plaintiffs, and although it certainly appeared that the number of lawsuits would increase, the panel decided not to approve an MDL on the basis of possible future lawsuit claims.

However, the claims of Lipitor type II diabetes continued to pour in, the number increasing from just a few, to now nearly 1,000 claims.

The US Judicial Panel on Multidistrict Litigation has now looked into it again, and decided to create a Lipitor MDL, despite resistance from Pfizer. The panel concluded, “…centralization will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation.”

Read the official release from the Judicial Panel on Multidistrict Litigation here. 

The Lipitor type II diabetes claims have now been centralized under the District of South Carolina; the cases are to be heard by the Honorable Judge Richard M. Gergel for “consolidated pretrial proceedings.”

Why an MDL is Beneficial to You

The Lipitor multidistrict litigation is a way of handling hundreds of similar claims, without making use of the class action lawsuit method.

Class action lawsuits are a single lawsuit filed from multiple plaintiffs, and any compensation award is then divided evenly between the plaintiffs. The Lipitor lawsuit is not technically a class action lawsuit, which is a common misconception.

Here why this is good news to you if you are considering filing a Lipitor lawsuit:

In an MDL, each case that goes to court is considered individually. This means that settlements are award to the individual, with respect to their unique situation and medical needs. Some claimants have been hurt more than others, and will require higher amounts of compensation to cover their medical costs and losses.

Lipitor attorneyIn a class action lawsuit, sometimes so many plaintiffs join that after legal fees, individuals are issued very small checks that have been divided among the masses. This won’t happen with an MDL. Instead, your own individual needs will be taken into consideration by a court of law, and the settlement awarded will be what the court considers fair.

This is another reason why it is so crucial to hire the right legal counsel to represent you in your Lipitor claim. Working with an experienced, well-informed Lipitor lawyer is the best thing you can do in order to get the compensation you deserve, and begin to heal.

Here at Consumer Claims Center of America we are proud to be working with the best pharmaceutical injury attorneys in the field, and if you are eligible for a claim we are confident that we can get you a maximum Lipitor settlement.

Our free consultation is simple and easy. Fill out the online Lipitor Lawsuit Form located on the right of this page, or simply call the number below to begin your Lipitor Lawsuit today.




All About the Lipitor Lawsuit

It’s Time to Fight Back

Another unfortunate drug injury litigation – Lipitor lawsuit – has hit the nation. The problems associated with drug injuries seem endless.

It's time to take a stand against the pharmaceutical giants.

It’s time to take a stand against the pharmaceutical giants and fight for our rights as healthcare consumers.

Is this because the pharmaceutical companies know very well that nothing can stop their business growth?

Are these practices justified?

We, citizens of this country, are the major part of this society. We drive the economy. Despite that, it seems the major pharmaceutical companies are in control when it comes to our health. 

Pfizer now has another class action lawsuit on its hands. Lipitor lawsuit is a drug injury litigation filed by women and men in the U.S.


How Does Lipitor Work?

As we mentioned earlier, the medication, which belongs to the statin class, was first introduced in the market to help patients lower cholesterol.

Lipitor received FDA approval in the year 1996.

By preventing an enzyme from producing low density lipids in the liver, the drug helps to lower cholesterol. It sounds useful as the low density lipids can block major heart arteries and cause heart complications.

However, why did people file Lipitor lawsuit if the drug was so helpful?

The issues start from here - 

Reasons to File Lipitor Lawsuit?

The people of this country have seen pharmaceutical companies putting their profits before health in the past. It is hard to say what their intentions really are when we see them marketing dangerous drugs. 

If the drug companies decide to mislead the common man of this country with appealing marketing and advertising campaigns, they will. The profits they can make off of these drugs are larger than the cost of the inevitable lawsuits.

Lipitor settlement

When drug companies make profits their #1 priority, it comes at a high price to consumers.

The culture of excessive dependence on prescription drugs has made the situation even worse. Addressing a health complication seems easier with the help of the pills. These pharmaceutical companies are well versed with the fact and they take advantage of the situation. 

Why do these companies behave so unethically? The bottom line is money. 

Although the companies won’t admit acts of ignorance or negligence directly, nobody else other than them can be held responsible for mass product injury.

It’s the drug manufacturer’s responsibility to make sure their medications are safe for the public use.

Filing a Lipitor lawsuit against Pfizer seems to be the right thing to do because the company never took the responsibility to clearly warn the consumers about the drug’s possible side effects. 

Lipitor Lawsuit: The Drug Induced Side Effects

The most prevalent Lipitor side effect in the courts right now is Lipitor type II diabetes.

You may be able to file a claim against Lipitor if you’ve been diagnosed with the condition after using the drug for a while.

There are also some mild side effects of the drug that you should be aware of:

You might notice an indigestion problem, gas, nausea, diarrhea, headache, tiredness, stomach cramps, throat irritation or even infrequent bowel movements.

Apart from type 2 diabetes, patients taking the drug may also have to suffer complications like kidney failure and liver problems. If you notice any of these problems after using the drug for some time, you may be eligible to win a Lipitor settlement in a court of law.

Lipitor Lawsuit: Studies Showing Connection Between Lipitor and its Side Effects

There are many studies that show the link between the cholesterol lowering drug and its side effects. Here are just a few:

In the year 2010, The Atherosclerosis study showed that the daily dose of the drug Lipitor triggered diabetes in women. These women didn’t have any pre-existing diabetes condition.

There was a 2010 meta-analysis conducted by “The Lancet” that reviewed several other studies conducted on patients taking Lipitor and other statins. The study found that patients showed a 9% higher chance of developing type 2 diabetes after using the drug.

A study published in the Journal “Archives of Internal Medicine” in 2012 found women aged between 50 and 79, who took the drug Lipitor to reduce cholesterol level, had a 48% higher risk of developing type 2 diabetes.

Lipitor Lawsuit: Quick Facts

Why did the drug come under scrutiny suddenly?

Because the manufacturer launched the drug in the market to help women lower cholesterol, but their medication ended up creating additional health problems for them.

To be precise, Lipitor, which is the brand name of the generic drug atorvastatin, has been found to be a precursor of type 2 diabetes, rhabdomyolysis, kidney and liver damage.

Filing a Lipitor Lawsuit Makes Sense

After seeing the rising number of drug injury cases nationwide, sometimes it feels as though the companies are using us, the healthcare consumers as lab rats.

Nobody likes to enter into the complications of a litigation. Unfortunately, that’s the only way you can make a giant pharmaceutical company liable for its actions.

The Lipitor lawsuit was filed when the cholesterol lowering drug manufactured by Pfizer was seen to be causing type 2 diabetes in women and others. These victims took the medicine to get rid of their cholesterol, and were subsequently diagnosed with more serious conditions as a side effect of Lipitor, such as type II diabetes and rhabdomyolysis. 

Lipitor attorneyThis is not a situation that should be treated lightly.

Hire a Lipitor attorney and demand the loss coverage.

Be a part of the national protest.

We can advise you how.

Our Lipitor lawyers, who have an extensive exposure in handling numerous drug injury cases, can take you through all types of courtroom formalities.

First we will help you make sure you qualify for the litigation. All you have to do is provide us with the requested information via the online Lipitor Lawsuit Form.

We’ll evaluate your eligibility based on the information you give to us. We will then schedule an appointment to help you take your Lipitor lawsuit forward. 

Or simply call:


Filing a Lipitor lawsuit won’t be easy without the help of the professionals. The process is very complicated and time consuming-and that’s where we come in.

We know if you have been hurt by Lipitor you have your own health problems to tend to: Let us do the legal leg-work.

We will fight for your rights as a healthcare consumer and win you the biggest settlement possible, as your medical costs and other losses will likely be high from such severe Lipitor side effects.

We work with the major players in the Lipitor lawsuit, and are specialized in this type of case. We do not charge a fee unless you collect a settlement. Contact us today to get your Lipitor lawsuit started as soon as possible!

Lipitor Lawsuits in the News

The Lipitor lawsuits are gaining momentum as the number of plaintiffs have recently skyrocketed, drawing media attention.

health newsSources close to the case reported that as of April 15th, 2014 the Lipitor lawsuit had 464 claims of Lipitor induced type II diabetes.

Only one month later, the number of Lipitor diabetes claims had nearly doubled, with an astonishing 703 claims filed as of May 15th. Due to media attention and an increasing number of affected victims of this popular cholesterol reducing drug, the lawsuit is taking off.

If you have been affected by Lipitor, now is the time to contact us for a free case evaluation, as the Lipitor lawsuit is currently underway, and Lipitor settlements will come soon.

New FDA Guidelines for Lipitor

Developing serious Lipitor side effects such as type II diabetes is relatively rare, although Lipitor certainly does present a substantial risk.

The claimants in the Lipitor lawsuit allege (and we tend to agree) that Pfizer did not properly and clearly warn them of the risks involved with taking the drug.

Were Pfizer more forthcoming about the risks of statin drugs such as Lipitor, patients and healthcare providers alike could have been on the lookout for the development of serious side effects.

For example, patients taking long term courses of Lipitor may have been able to avoid type II diabetes altogether if they had known they should have been monitoring their blood sugar levels, and watching for other tell-tale signs of oncoming type II diabetes.

That being said, the risk for developing serious Lipitor side effects is still small. Thus, the FDA has now approved Lipitor for use as a preventative medication.

Lipitor is currently used as a treatment for people with high cholesterol levels, which are associated with heart disease and stroke.

The new guidelines allow healthcare providers to prescribe Lipitor to prevent high cholesterol as well.

According to a report earlier this year from  Kaiser Health News, the new guidelines for Lipitor prescription could result in approximately half of all Americans over the age of 40 taking statin drugs such as Lipitor.

While the chances of developing severe Lipitor side effects are relatively low, the new guidelines could potentially mean up to 13 million more Americans being prescribed Lipitor or other statin drugs.

So although serious Lipitor side effects only develop in a small percentage of those who take it, the number of people taking this drug will be so high that undoubtedly thousands lipitor claims lipitor side effectsand ultimately millions of Americans will develop Lipitor side effects such as type II diabetes or rhabdomyolysis.

Unless Pfizer steps up its warnings about the more serious side effects of Lipitor, this also means that the number of Americans effected by Lipitor type II diabetes and other conditions will also increase wildly.

It is presumed that we will soon see an even further increase in the amount of Lipitor claims made against Pfizer for this reason.

Simply put, since Lipitor can now be used as a means of preventing cholesterol related problems. More people will be taking Lipitor, and because of that more people will also be hurt by Lipitor side effects unless Pfizer and healthcare providers make some major changes.

Don’t fall victim to this giant corporation’s unethical practices. The best thing we can do as consumers is educate ourselves.

Unfortunately for many, it is too late to avoid serious Lipitor side effects. The Lipitor lawsuits are a way for injured consumers to fight back and recoup their losses, if only financially. Lipitor side effects can and do create costly medical bills, loss of wages, and pain and suffering.

If you feel as though you have been adversely affected by Lipitor in this way, don’t hesitate to contact us at Consumer Claims Center of America; we can help.

Beginning your Lipitor lawsuit is a quick and easy process. Simply fill out the Lipitor Lawsuit Form on the upper-right hand corner of this page, or call our toll free number below for a free consultation.


Pfizer and the Upcoming Lipitor Settlement

Pfizer and the Upcoming Lipitor Settlement

lawsuitPfizer is being sued by hundreds of women who claim they developed type II diabetes due to the usage of Lipitor, a cholesterol lowering drug. Studies have demonstrated that there is a direct link between Lipitor and an increased risk of this particular disease.

It is predicted that thousands of women will soon establish lawsuits against Pfizer, leading to Lipitor settlements. Pfizer is now under the spotlight for failing to disclose the serious adverse effects of Lipitor.

Pfizer is now being pushed to reach a Lipitor settlement, just as in the past it was pressured to reach a settlement for 2.9 billion dollars for violating the False Claims Act on their drugs Bextra, Geodon, Zyvox and Lyrica.

Although it is relatively unknown as to how much Pfizer will have to pay for settlements, but it is likely it will only be a small fraction of the $11 billion + that Lipitor earns annually.

Lipitor Side Effects

Lipitor is the brand name of the drug atorvastatin. It is a member of the family of drugs called statins which lowers levels of LDL cholesterol (also known as “bad” cholesterol) and triglycerides. It also reduces heart attacks and other heart related conditions.

Side effects listed by Pfizer are:

· Confusion and memory problems

· Muscle pain and weakness for no apparent reason

· Fever, tiredness and dark urine color and stools as well as jaundice

· Increase in thirst, hunger, dry mouth and skin, weight loss

· Other less serious side effects such as nausea

Type II diabetes is not a side effect listed by Pfizer even though there may be evidence that they knew about it beforehand and decided not to disclose it.

In 2011, the FDA (U.S. Food and Drug Administration) ran an investigation on Lipitor and found that indeed Lipitor caused imbalances in glucose levels, and significantly incrlipitor settlement lawsuit 3eased the risk of contracting type II diabetes.

After concluding the investigation the FDA obliged Pfizer to change its label warnings. However, the new Lipitor label warning still doesn´t explicitly say that the drug may cause type II diabetes, and many people are still to this day falling victims of this drug.

Both past and future victims are entitled for a Lipitor settlement for damages incurred. Pfizer utilized unethical business practices at the cost of their consumers’ health, and the lawsuits and settlements to follow are but a small consequence compared to the loss of health in those who were injured by Lipitor.

Studies Linking Lipitor to Type II Diabetes

Annually, Lipitor makes billions of dollars in sales, which are Pfizer’s primary concern- not your health. Lipitor is the worlds best selling drug, and it is shocking to healthcare providers and patients alike to find that such a popular drug has such serious and yet hidden side effects.

This financially successful drug has produced devastating results in the population regularly taking it. It is stated that Pfizer knew or at least should have known about the increased risk for type II diabetes given the various studies performed when testing a drug for commercial human use.

Lipitor settlements can and should be claimed if victims realized they were cheated by Pfizer´s fraudulent practices. It is the responsibility of the drug manufacturer, in this case Pfizer, to ensure the safety of their drugs before releasing them to the public.

Many studies have now been conducted by medical institutions independent of Pfizer since the release of this drug in 1996. They showed that it does work for lowering cholesterol levels but they have also shown that its side effects are severe and not as mild as what Pfizer alleged and published when they initially released the drug in 1996.

Here is a brief listing of relevent studies regarding the use of Lipitor and type II diabetes:

1) In 2010 the medical journal “The Lancet” published a study correlating risk increase of type II diabetes and Lipitor use in women taking it. The study compared two groups of women. The first group was taking Lipitor and second group did not. The study concluded that the prevalence of Type II Diabetes was significantly higher in women taking Lipitor.

2) The journal “Circulation: Cardiovascular Quality and Outcomes” stated that Lipitor and statins in general are effective in lowering cholesterol levels. In 2004 however, a new study showed that Lipitor use caused the body to have a decreased ability to control blood glucose levels when taken in large doses.

3) In March 2011, a study published on the Journal of the American College of Cardiology also showed a prevalence of Type II Diabetes in women taking Lipitor.

4) In 2013, after a 5 year study with more than 100,000 post-menopausal women in 40 medical centers across the United States the JAMA medical journal finally concluded that Lipitor and other statins increased the risk of type II diabetes in that specific population (post-menopausal women). The study also concluded that women with a BMI (body mass index) below 30 have an increased risk of type II diabetes than women with a BMI above 30, which is unusual.

Statins in general were linked with an increased risk of type II diabetes. Lipitor is a high-potency statin compared to other moderate and low potency statins such as Lovastatin and Fluvastatin, putting Lipitor users at a higher risk of getting type II diabetes.

Elderly woman thumbs downThe development of type II diabetes can be a very uncomfortable and life changing experience for individuals and families. They have to start testing their glucose levels on a regular basis, which means they will have to undergo needle pricks several times a day. They will also have to change their whole lifestyle and restrict themselves to a diabetic diet. Additionally there is research showing that these individuals now have a shortened lifespan, and will have to deal with high medical bills and expenses.

On top of that, type II diabetes is a chronic disease. Sufferers will have to start taking medications for the diabetes itself  which will further put their health at risk because of the side effects of the new medications.

For many who took or are taking Lipitor, the quality of life for the individual has been greatly diminished: physically, emotionally and financially, Lipitor victims are prompted to take action against Pfizer for its unethical practices.

Lawsuits and Lipitor Settlement

If you are a woman who is suffering from type II diabetes and has taken Lipitor before for the purpose of reducing your cholesterol you may be eligible to make a claim and reach a Lipitor settlement.

Lipitor settlements will be valid in any case that there is a proof that it was the Lipitor who caused the type II diabetes. Lipitor settlements can´t take place if there is no valid proof or under other conditions. To establish whether a person should claim for a Lipitor settlement, please contact us, Consumer Claim Centers of America to study the case.

A Lipitor settlement is a resolution between the two opposing parties: the victim and Pfizer. If a settlement agreement is not reached, all of the attorneys we work with are well prepared to go to court.

A Lipitor settlement will probably give compensation to victims depending on a variety of factors such as:

-The severity of the damage done by Lipitor

-Mental and emotional detriment caused to the individual

-The amount of money the person will spend in the future on related medical costs

-Any monetary loss resulting from inability to work or have a job due to Lipitor´s side effects

An approximate Lipitor settlement sum for an average person suffering type II diabetes is around $200,000.

BalanceLipitor settlements will be looked at on an individual basis as each person was hurt in varying degrees by Pfizer´s drug.

It is likely that Pfizer will decide to make a Lipitor settlement offer for a lower amount of money to the accusers rather than leave it up to a jury to decide.

This might be the way Pfizer proceeds because waiting for a Lipitor settlement after the jury´s resolution can make Pfizer incur higher legal costs and increased sanctions. In this case the plaintiff has the choice of accepting or rejecting that Lipitor settlement as he or she wishes.

If the plaintiff feels comfortable with the Lipitor settlement offer, they can decide to accept it. If they don´t feel comfortable with the Lipitor settlement offer, they can decide to wait until the jury gives the final Lipitor settlement for that particular case.

Contact us to guide you in the legal process required to reach a Lipitor settlement. We will answer any questions you may have, and begin managing your claim immediately. Please fill out the online form on the top right-hand corner of this page, or call the toll-free number below.


 Page 1 of 2  1  2 »